A NEW PROSPECT FOR BODY MANAGEMENT ?

Scientists are excitedly examining retatrutide, a innovative drug developed by Eli Lilly, as a possible breakthrough in body management. Unlike many earlier approaches, retatrutide is a double -action receptor targeting simultaneously GLP-1 and GIP, hormones that influence hunger and blood sugar